Trump drug price plan could nix investment, warns Roche / Photo: SEBASTIEN BOZON - AFP
-
Rohit and Rickelton power Mumbai to IPL win over Kolkata
-
Russian tanker nears Cuba, defying US oil blockade
-
'Project Hail Mary' tops N. America box office for second week
-
Forty new migratory species win international protection: UN body
-
Freed whale gets stranded again on German coast
-
Ter Stegen's World Cup chances 'very slim', says Nagelsmann
-
Pakistan hosts Saudi, Turkey, Egypt for talks on Mideast war
-
Tudor leaves after just seven games as Spurs battle for survival
-
Philipsen sprints to In Flanders Fields victory
-
In Israel, air raid sirens spark anxiety and dilemmas
-
Iran accuses US of plotting ground attack despite diplomatic talk
-
Vingegaard clinches Tour of Catalonia victory
-
Despondent Verstappen questions Formula One future
-
Two more arrests over attempted attack on US bank HQ in Paris
-
Nepal's ex-PM attends court hearing in protest crackdown case
-
Iran parliament speaker says US planning ground attack
-
Despondent Verstappen says Red Bull woes 'not sustainable'
-
Piastri says Japan second place 'as good as a win' for McLaren
-
Nepal's former energy minister arrested in graft probe
-
IOC reinstating gender tests 'a disrespect for women' - Semenya
-
Youngest F1 title leader Antonelli to keep 'raising bar' after Japan win
-
High hopes at China's gateway to North Korea as trains resume
-
Antonelli wins in Japan to become youngest F1 championship leader
-
Mercedes' Antonelli wins Japanese Grand Prix to take lead
-
Germany's WWII munitions a toxic legacy on Baltic Sea floor
-
Iran claims aluminium plant attacks in Gulf as Houthis join war
-
North Korea's Kim oversees test of high-thrust engine: state media
-
Five Apple anecdotes as iPhone maker marks 50 years
-
'Excited' Buttler rejuvenated for IPL after horror T20 World Cup
-
Ship insurers juggle war risks for perilous Gulf route
-
Helplines buzz with alerts from seafarers trapped in war
-
Let's get physical: Singapore's seniors turn to parkour
-
Indian tile makers feel heat of Mideast war energy crunch
-
At 50, Apple confronts its next big challenge: AI
-
Houthis missile attacks on Israel widen Middle East war
-
Massive protests against Trump across US on 'No Kings' day
-
Struggling Force lament missed opportunities after Chiefs defeat
-
US thrashed 5-2 by Belgium in reality check for World Cup hosts
-
A Bright New Era in Electric Mobility - Accelerating the Future of Energy
-
China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
-
Lakers guard Doncic gets one-game ban for accumulated technicals
-
Houthis claim missile attacks on Israel, entering Middle East war
-
NBA Spurs stretch win streak to eight in rout of Bucks
-
US lose 5-2 to Belgium in rude awakening for World Cup hosts
-
Sabalenka sinks Gauff to win second straight Miami Open title
-
Lebanon kids struggle to keep up studies as war slams school doors shut
-
Cherry blossoms, kite-flying and 'No Kings' converge on Washington
-
Britain's Kerr to target El Guerrouj's mile world record
-
Sailboats carrying aid reach Cuba after going missing: AFP journalist
-
Pakistan to host Saudi, Turkey, Egypt for talks on Mideast war
Trump drug price plan could nix investment, warns Roche
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in the United States, it said Wednesday.
Trump signed an executive order Monday aimed at bringing down the notoriously high prescription drug prices paid by US consumers, news that rattled pharmaceutical companies.
Swiss newspaper NZZ reported Trump's move could lead Roche to reassess plans it announced just last month to invest $50 billion in the United States over five years.
Roche, the world leader in cancer treatments, said in a statement it did not expect Trump's new drugs policy to hurt its business in 2025.
"However, should the proposed EO (executive order) go into effect, Roche's ability to fund the significant investments previously announced in the US will be in question," it said.
Trump has been pushing foreign firms to invest more in the United States, saying the way to avoid his tariff assault on foreign-made goods is to produce them on US soil instead.
Prescription drugs were not targeted in Trump's "Liberation Day" tariff announcements.
Still, Roche appeared to take heed with its April investment announcement, which came just after fellow Swiss rival Novartis said it would increase investment in the United States by $23 billion over five years.
The United States is a key market for Roche, accounting for more than half its pharmaceutical division's revenues.
Roche's US subsidiary Genentech announced a $700-million project Monday to build a new plant in North Carolina, which it says would employ 400 people.
E.Hall--AT
